Advertisement
Advertisement
A worker wearing a protective suit swabs a woman’s throat in a Covid-19 test in May 2022. In the pandemic’s wake, the formation of a global partnership to study emerging infectious diseases is a positive step. Photo: AP
Opinion
Editorial
by SCMP Editorial
Editorial
by SCMP Editorial

Hong Kong must learn lesson after Covid-19 to deal with the next threat

  • Top scientists from the city form global partnership that stresses the need to be prepared to fight future pandemics

The Covid-19 pandemic seems like history now. Officially, it is no longer classified as a public health emergency of international concern.

That does not mean we are completely risk-free, though. Some people continue to wear masks wherever they go, and self-test kits are commonly used.

Many are still living under the shadow of the disease, either coping with its long-term effects or the loss of loved ones. The health crisis remains a painful experience from which lessons have yet to be fully learned.

The initiative by Columbia University virologist Professor David Ho and the University of Hong Kong microbiologist Professor Yuen Kwok-yung to create a global partnership to study emerging infectious diseases is a positive step that will enhance preparedness for challenges that may lie ahead. Also joining the “Pandemic Research Alliance” are mainland China’s Tsinghua University and Doherty Institute/University of Melbourne in Australia.

Focusing on respiratory viruses transmitted from person to person, the alliance will pursue a comprehensive set of research initiatives on surveillance, diagnostics, antiviral drugs and monoclonal antibodies, viral evolution and resistance to therapeutics, antibody engineering, vaccine development and pathogenesis. “Once we define the most important threats, we could start to study them in greater detail to see if we could develop drugs, antibodies and vaccines, and get them ready,” Ho said.

The virologist needs no introduction, being one of the first to identify HIV and chart its effects on patients. Yuen is well known for his expertise in helping curb Covid-19 and worked with Ho to improve treatment options during the outbreak of severe acute respiratory syndrome (Sars) in 2003.

Academia has proved to be pivotal in helping to control infectious disease worldwide. Over the past three years, there have been experts advising the government on Covid-19 strategies.

Their presence will not only lend support to government policies and measures, but also help avoid or correct any missteps. That, of course, depends on how well their views are taken into account.

Ultimately, decisions are made by officials, having regard to science and other considerations.

Covid-19 is over in Hong Kong, but stress and anxiety linger on

That is why the authorities also have to seriously reflect on their approach and identify areas for improvement. So far, this appears not to have been taken as seriously as it should.

Even if internal reviews have been conducted, the public has not been kept informed of their outcomes. This only prevents different sectors from identifying their inadequacies and stalls attempts to address them.

We need to get ready for the next challenge. We will only be better prepared once we have learned such lessons.

2